Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Uhl

Showing results (381-390 of 526) with videos related to

Pageof 53
Sort By:
Genomics|December 1, 1992
Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTRD J Vandenbergh, A M Persico, A L Hawkins, et al.
Human Molecular Genetics|September 7, 2007
Neurexin 3 polymorphisms are associated with alcohol dependence and altered expression of specific isoformsAkitoyo Hishimoto, Qing-Rong Liu, Tomas Drgon, et al.
The Journal of Biological Chemistry|August 12, 1994
-mu opiate receptor. Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activityC K Surratt, P S Johnson, A Moriwaki, et al.
The Journal of Pharmacy and Pharmacology|November 15, 2024
Protein phosphatase 2A inhibitors: a possible pharmacotherapy for benzodiazepine dependenceChisa Kobayashi, Nobue Kitanaka, Masanori Nakai, et al.
Neuroscience|November 19, 2002
Antagonistic property of buprenorphine for putative epsilon-opioid receptor-mediated G-protein activation by beta-endorphin in pons/medulla of the mu-opioid receptor knockout mouseH Mizoguchi, H-E Wu, M Narita, et al.
Synapse (New York, N.Y.)|July 19, 2002
Effects of acute "binge" cocaine on preprodynorphin, preproenkephalin, proopiomelanocortin, and corticotropin-releasing hormone receptor mRNA levels in the striatum and hypothalamic-pituitary-adrenal axis of mu-opioid receptor knockout miceYan Zhou, Rudolph Spangler, Stefan D Schlussman, et al.
Pharmacology, Biochemistry, and Behavior|July 19, 2018
Tetrabenazine, a vesicular monoamine transporter-2 inhibitor, attenuates morphine-induced hyperlocomotion in mice through alteration of dopamine and 5-hydroxytryptamine turnover in the cerebral cortexNobue Kitanaka, Junichi Kitanaka, F Scott Hall, et al.
Human Heredity|July 1, 1993
Dopamine D2 receptor RFLPs, haplotypes and their association with substance use in black and Caucasian research volunteersB F O'Hara, S S Smith, G Bird, et al.
Diagnostic Microbiology and Infectious Disease|January 21, 2006
A real-time polymerase chain reaction assay for detection of Pneumocystis from bronchoalveolar lavage fluidRodney C Arcenas, James R Uhl, Seanne P Buckwalter, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 1997
Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesiaI Sora, N Takahashi, M Funada, et al.
Pageof 53

Showing results (381-390 of 526) with videos related to

Sort By:
Pageof 53
Genomics|December 1, 1992
Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTRD J Vandenbergh, A M Persico, A L Hawkins, et al.
Human Molecular Genetics|September 7, 2007
Neurexin 3 polymorphisms are associated with alcohol dependence and altered expression of specific isoformsAkitoyo Hishimoto, Qing-Rong Liu, Tomas Drgon, et al.
The Journal of Biological Chemistry|August 12, 1994
-mu opiate receptor. Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activityC K Surratt, P S Johnson, A Moriwaki, et al.
The Journal of Pharmacy and Pharmacology|November 15, 2024
Protein phosphatase 2A inhibitors: a possible pharmacotherapy for benzodiazepine dependenceChisa Kobayashi, Nobue Kitanaka, Masanori Nakai, et al.
Neuroscience|November 19, 2002
Antagonistic property of buprenorphine for putative epsilon-opioid receptor-mediated G-protein activation by beta-endorphin in pons/medulla of the mu-opioid receptor knockout mouseH Mizoguchi, H-E Wu, M Narita, et al.
Synapse (New York, N.Y.)|July 19, 2002
Effects of acute "binge" cocaine on preprodynorphin, preproenkephalin, proopiomelanocortin, and corticotropin-releasing hormone receptor mRNA levels in the striatum and hypothalamic-pituitary-adrenal axis of mu-opioid receptor knockout miceYan Zhou, Rudolph Spangler, Stefan D Schlussman, et al.
Pharmacology, Biochemistry, and Behavior|July 19, 2018
Tetrabenazine, a vesicular monoamine transporter-2 inhibitor, attenuates morphine-induced hyperlocomotion in mice through alteration of dopamine and 5-hydroxytryptamine turnover in the cerebral cortexNobue Kitanaka, Junichi Kitanaka, F Scott Hall, et al.
Human Heredity|July 1, 1993
Dopamine D2 receptor RFLPs, haplotypes and their association with substance use in black and Caucasian research volunteersB F O'Hara, S S Smith, G Bird, et al.
Diagnostic Microbiology and Infectious Disease|January 21, 2006
A real-time polymerase chain reaction assay for detection of Pneumocystis from bronchoalveolar lavage fluidRodney C Arcenas, James R Uhl, Seanne P Buckwalter, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 1997
Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesiaI Sora, N Takahashi, M Funada, et al.
Pageof 53